• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study.直接评估血浆低密度脂蛋白和高密度脂蛋白胆固醇水平与冠心病:弗雷明汉后代研究的结果。
Atherosclerosis. 2010 Nov;213(1):251-5. doi: 10.1016/j.atherosclerosis.2010.02.041. Epub 2010 Mar 9.
2
Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women.除了低密度脂蛋白胆固醇之外:非高密度脂蛋白胆固醇水平、甘油三酯以及总胆固醇/高密度脂蛋白胆固醇比值对貌似健康的男性和女性冠心病风险的各自影响。
J Am Coll Cardiol. 2009 Dec 29;55(1):35-41. doi: 10.1016/j.jacc.2009.07.057.
3
Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.洛伐他汀对胆固醇水平正常的男性和女性急性冠脉事件的一级预防:空军/德州冠状动脉粥样硬化预防研究(AFCAPS/TexCAPS)的结果
JAMA. 1998 May 27;279(20):1615-22. doi: 10.1001/jama.279.20.1615.
4
Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control.高血浆甘油三酯和低高密度脂蛋白胆固醇对低密度脂蛋白胆固醇控制达标后冠心病残余风险的贡献。
Am J Cardiol. 2010 Sep 15;106(6):757-63. doi: 10.1016/j.amjcard.2010.05.002. Epub 2010 Aug 1.
5
Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.普伐他汀对2073例低密度脂蛋白胆固醇和高密度脂蛋白胆固醇水平均较低患者冠状动脉事件的影响:LIPID研究结果
Eur Heart J. 2004 May;25(9):771-7. doi: 10.1016/j.ehj.2004.03.013.
6
Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.弗明汉后代研究中年龄、性别和绝经状态对血浆低密度脂蛋白胆固醇及载脂蛋白B水平的影响。
J Lipid Res. 1994 May;35(5):779-92.
7
Lipid measurements in the management of cardiovascular diseases: Practical recommendations a scientific statement from the national lipid association writing group.脂质测量在心血管疾病管理中的应用:实用建议——国家脂质协会写作组的科学声明。
J Clin Lipidol. 2021 Sep-Oct;15(5):629-648. doi: 10.1016/j.jacl.2021.09.046. Epub 2021 Sep 24.
8
Small dense LDL cholesterol and coronary heart disease: results from the Framingham Offspring Study.小而密 LDL 胆固醇与冠心病:弗雷明汉后代研究的结果。
Clin Chem. 2010 Jun;56(6):967-76. doi: 10.1373/clinchem.2009.137489. Epub 2010 Apr 29.
9
Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.以高密度脂蛋白胆固醇水平低为特征的人群中血脂异常的风险判定
Am Heart J. 2003 Dec;146(6):1052-9. doi: 10.1016/S0002-8703(03)00516-7.
10
Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.阿托伐他汀对冠心病患者与对照受试者空腹及餐后脂蛋白亚类的影响。
Am J Cardiol. 2002 Oct 1;90(7):689-96. doi: 10.1016/s0002-9149(02)02591-2.

引用本文的文献

1
Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.小而密的低密度脂蛋白胆固醇是前瞻性弗雷明汉后代研究中最具致动脉粥样硬化作用的脂蛋白参数。
J Am Heart Assoc. 2021 Feb;10(5):e019140. doi: 10.1161/JAHA.120.019140. Epub 2021 Feb 15.
2
Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population.在一个大型的日本人群中,吸烟状况、心血管危险因素与脂蛋白之间的关系。
J Atheroscler Thromb. 2021 Sep 1;28(9):942-953. doi: 10.5551/jat.56838. Epub 2020 Oct 28.
3
Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression.小而密的低密度脂蛋白胆固醇与颈动脉内膜中层厚度的进展。
J Atheroscler Thromb. 2020 Oct 1;27(10):1108-1122. doi: 10.5551/jat.54130. Epub 2020 Apr 10.
4
Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.脂蛋白亚组分与台湾地区糖尿病前期和糖尿病患者的血糖稳态
J Atheroscler Thromb. 2019 Oct 1;26(10):890-914. doi: 10.5551/jat.48330. Epub 2019 Feb 7.
5
Effectiveness and safety of combinational therapy compared with intensified statin monotherapy in patients with coronary heart disease.冠心病患者联合治疗与强化他汀单药治疗的有效性和安全性比较。
Exp Ther Med. 2018 Jun;15(6):4683-4688. doi: 10.3892/etm.2018.6024. Epub 2018 Apr 2.
6
Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State.低密度脂蛋白胆固醇(LDL-C)和高密度脂蛋白胆固醇(HDL-C)的均相测定法在餐后和空腹状态下均可靠。
J Atheroscler Thromb. 2017 Jun 1;24(6):583-599. doi: 10.5551/jat.40006. Epub 2017 Mar 17.
7
Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients.一种估算糖尿病患者低密度脂蛋白胆固醇水平的新方法的有效性
J Atheroscler Thromb. 2016 Dec 1;23(12):1355-1364. doi: 10.5551/jat.35972. Epub 2016 Sep 2.
8
WDR1 and CLNK gene polymorphisms correlate with serum glucose and high-density lipoprotein levels in Tibetan gout patients.WDR1和CLNK基因多态性与藏族痛风患者的血糖和高密度脂蛋白水平相关。
Rheumatol Int. 2016 Mar;36(3):405-12. doi: 10.1007/s00296-015-3378-y. Epub 2015 Oct 5.
9
Measuring Low Density Lipoprotein Cholesterol: Comparison of Direct Measurement by HiSens Reagents and Friedewald Estimation.测量低密度脂蛋白胆固醇:高灵敏度试剂直接测量法与Friedewald估算值的比较
Korean J Fam Med. 2015 Jul;36(4):168-73. doi: 10.4082/kjfm.2015.36.4.168. Epub 2015 Jul 17.
10
Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe.与盐酸考来维仑和依折麦布相关的胆固醇治疗模式及心血管临床结局
Drugs Aging. 2014 Sep;31(9):683-94. doi: 10.1007/s40266-014-0200-6.

本文引用的文献

1
Comparative study between anion-exchange HPLC and homogeneous assay methods in regard to the accuracy of high- and low-density lipoprotein cholesterol measurement.阴离子交换高效液相色谱法与均相测定法在高密度脂蛋白胆固醇和低密度脂蛋白胆固醇测量准确性方面的比较研究。
Clin Biochem. 2007 Nov;40(16-17):1291-6. doi: 10.1016/j.clinbiochem.2007.07.008. Epub 2007 Aug 10.
2
Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.不同血脂指标对男性和女性冠心病预测的临床效用。
JAMA. 2007 Aug 15;298(7):776-85. doi: 10.1001/jama.298.7.776.
3
Nonfasting low-density lipoprotein testing: utility for cholesterol screening in pediatric primary care.非空腹低密度脂蛋白检测:在儿科初级保健中用于胆固醇筛查的效用
Clin Pediatr (Phila). 2007 Jun;46(5):441-5. doi: 10.1177/0009922806297752.
4
Falsely low LDL-cholesterol concentrations and artifactual undetectable HDL-cholesterol measured by direct methods in a patient with monoclonal paraprotein.单克隆副蛋白血症患者中通过直接法测得的低密度脂蛋白胆固醇浓度假性降低及高密度脂蛋白胆固醇假性无法检测。
Clin Chim Acta. 2005 Aug;358(1-2):192-5. doi: 10.1016/j.cccn.2005.02.008.
5
Evaluation of methods for the measurement of low-density lipoprotein cholesterol.低密度脂蛋白胆固醇测量方法的评估
J Cardiovasc Pharmacol Ther. 2005 Mar;10(1):45-54. doi: 10.1177/107424840501000106.
6
[Multicenter evaluation of four homogenous LDL-cholesterol assays].[四种均一性低密度脂蛋白胆固醇检测方法的多中心评估]
Ann Biol Clin (Paris). 2005 Jan-Feb;63(1):27-41.
7
High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study.弗雷明汉后代研究男性参与者的高密度脂蛋白亚群分布与冠心病患病率
Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7. doi: 10.1161/01.ATV.0000146325.93749.a8. Epub 2004 Sep 23.
8
Lipid analyses for the management of vascular diseases.用于血管疾病管理的脂质分析
J Atheroscler Thromb. 2004;11(4):190-9. doi: 10.5551/jat.11.190.
9
Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation.低密度脂蛋白胆固醇的测量方法:对免疫比浊法直接测量与计算法的批判性评估
Clin Chem. 2002 Feb;48(2):236-54.
10
Homogeneous assay for measuring low-density lipoprotein cholesterol in serum with triblock copolymer and alpha-cyclodextrin sulfate.使用三嵌段共聚物和硫酸α-环糊精测定血清中低密度脂蛋白胆固醇的均相分析方法。
Clin Chem. 1998 Mar;44(3):522-31.

直接评估血浆低密度脂蛋白和高密度脂蛋白胆固醇水平与冠心病:弗雷明汉后代研究的结果。

Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring Study.

机构信息

Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, 711 Washington Street, Boston, MA 02111, USA.

出版信息

Atherosclerosis. 2010 Nov;213(1):251-5. doi: 10.1016/j.atherosclerosis.2010.02.041. Epub 2010 Mar 9.

DOI:10.1016/j.atherosclerosis.2010.02.041
PMID:20863498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3707385/
Abstract

BACKGROUND

We evaluated direct low density lipoprotein (LDL) cholesterol (C) and high density lipoprotein (HDL) cholesterol (C) versus standard methods using fasting plasma samples from participants in cycle 6 of the Framingham Offspring Study.

METHODS

Direct LDL-C and HDL-C measurements were performed on fasting plasma from male (1335 controls, 173 CHD cases) and female (1606 controls, 74 cases) participants, and compared with LDL-C, as calculated with the Friedewald formula, and HDL-C, as measured after dextran-Mg(2+) precipitation.

RESULTS

Values for direct LDL-C and HDL-C correlated well with standard methods (both about r(2)=0.94, p<0.001) with similar absolute values. Biases of >10% were present for 7.7% of samples for LDL-C, while for HDL-C this value was 8.5%. Despite higher use of cholesterol-lowering medication in CHD cases, calculated or direct LDL-C values were still well above recommended values [<2.6 mmol/L (100 mg/dL)] in CHD cases, especially in females.

CONCLUSIONS

Direct assays for both LDL-C and HDL-C provide an acceptable guide for lipid treatment. In Framingham Offspring Study participants most CHD cases had LDL-C levels above the recommended target.

摘要

背景

我们评估了直接低密度脂蛋白(LDL)胆固醇(C)和高密度脂蛋白(HDL)胆固醇(C)与使用弗雷明汉后代研究第 6 周期参与者的空腹血浆样本的标准方法。

方法

对男性(1335 名对照者,173 名 CHD 病例)和女性(1606 名对照者,74 名病例)参与者的空腹血浆进行直接 LDL-C 和 HDL-C 测量,并与 LDL-C(用 Friedewald 公式计算)和 HDL-C(用葡聚糖-Mg(2+)沉淀后测量)进行比较。

结果

直接 LDL-C 和 HDL-C 值与标准方法相关性良好(均约 r(2)=0.94,p<0.001),绝对值相似。LDL-C 有 7.7%的样本偏差>10%,而 HDL-C 为 8.5%。尽管 CHD 病例中使用了更多的降胆固醇药物,但计算或直接 LDL-C 值仍远高于推荐值[<2.6 mmol/L(100 mg/dL)],尤其是女性。

结论

直接 LDL-C 和 HDL-C 测定值为脂质治疗提供了可接受的指导。在弗雷明汉后代研究参与者中,大多数 CHD 病例的 LDL-C 水平高于推荐目标。